rfhg_143558.1

Basic information about the TSS

---

TSS ID: rfhg_143558.1 TSS ID(Version3): hg_116862.1 hg_116861.1 Species: human Chr: chr11		Start: 117144265 End: 117144341 Strand: +
Source datasets	FANTOM5|DRA000914|PRJNA4843412|DRA013844|PRJNA597322 |PRJNA548673|PRJNA401781|PRJNA615891|PRJDB5282
Protocol	CAGE|NETCAGE|STRIPE-seq|ReCappable-seq|SLIC_CAGE|TIF-seq2 |C1CAGE|RAMPAGE
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2502041,EH38E1573037)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000419197.6:0 ENST00000527958.6:0 ENST00000304808.10:0 ENST00000529887.6:0 ENST00000526888.1:0 AK292973:0 AK307366:0 BC000398:0 BC019301:0 FJ224328:0 GQ891510:0 BC039721:0 D63390:0 BC001774:0 GeneID: 5049 HGNC/MGI_ID: HGNC:8575 UniProt_ID: J3KNE3 P68402 Q9BUZ1 V9HW44 Nearer transcript ids and distances: ENST00000530272.1:3 DQ836743:3 DQ836742:3 DQ836741:3 DQ836738:3 DQ836739:3 DQ836740:3 ENST00000533206.1:41 view more...

Gene_name: platelet activating factor acetylhydrolase 1b catalytic subunit 2 Gene_symbol: PAFAH1B2 Gene_synonyms: Gene_source: HGNC:8575

TATA-Box annotation

---

Distance to TSS:	16
Nearest PromoterID:	NM_001309431
Entrez ID:	5049
Nearest Unigene:	Hs.728488
Nearest Refseq:	NM_002572
Nearest Ensembl:	ENSG00000168092
Gene Name:	platelet activating factor acetylhydrolase 1b catalytic subunit 2
Gene Alias:	HEL-S-303
Gene Type:	protein-coding
CpG%:	0.092105
GC%:	0.740260
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PAFAH1B2 p2@PAFAH1B2 p3@PAFAH1B2 p4@PAFAH1B2
Sample		p1@PAFAH1B2	p2@PAFAH1B2	p3@PAFAH1B2	p4@PAFAH1B2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	46.56	3.31	11.49	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	49.16	2.63	8.09	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	44.75	2.51	11.77	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	42.41	2.29	10.81	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	47.24	4.05	11.70	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	48.65	1.94	8.14	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	44.45	3.70	8.50	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	46.26	1.70	8.96	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	42.96	1.92	11.54	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	41.15	2.32	6.38	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	27.08	0.40	9.30	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	34.15	1.22	4.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.34	1.29	5.32	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	24.21	1.20	5.56	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	29.86	0.88	3.95	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	24.39	0.75	6.79	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.88	0.87	6.77	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	17.29	0.42	10.12	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	18.13	0.00	10.13	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.52	1.05	7.07	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	24.19	1.47	7.22	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	22.61	0.86	8.11	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	21.84	1.29	5.17	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	23.05	0.49	7.77	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	21.93	1.03	3.87	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.16	0.95	5.38	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.33	1.65	7.69	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	37.96	1.65	8.25	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	22.13	1.29	8.56	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	29.32	1.63	10.32	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	22.82	1.88	6.28	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.01	0.00	7.23	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	22.58	0.63	9.71	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	24.91	1.32	10.23	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	27.11	1.68	9.35	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	29.13	1.15	11.31	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	22.28	1.23	12.67	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	25.39	1.01	5.24	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	28.90	1.08	9.18	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	27.61	0.72	7.44	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	24.23	1.41	7.29	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	28.55	0.88	8.78	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	33.11	1.05	8.01	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.10	1.40	11.54	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	31.52	1.00	7.43	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.85	0.47	10.70	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	33.11	0.48	10.32	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	34.28	0.89	7.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	37.34	1.68	10.77	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	37.61	0.81	8.49	2.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	31.36	1.23	9.63	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	34.47	0.22	14.23	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	293.84	13.99	1455.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	33.36	0.71	15.97	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	31.81	0.66	11.60	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	99.83	4.19	31.04	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	43.63	0.46	15.15	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	34.36	0.32	15.88	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	29.23	1.61	19.91	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	32.69	0.63	27.03	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	42.30	1.41	29.61	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	38.69	0.56	16.82	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	45.38	1.59	39.81	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	35.68	2.04	15.63	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	40.29	1.62	25.67	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	33.72	1.06	23.07	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	355.61	0.00	1891.18	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	315.90	23.69	655.49	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	52.16	1.46	19.01	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	48.60	3.47	11.90	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	38.00	1.41	12.67	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	34.11	0.99	17.88	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	39.91	1.55	24.44	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	43.72	2.14	23.24	3.06
Adipocyte - breast, donor1	11376-118A8	45.61	2.22	1.90	0.32
Adipocyte - breast, donor2	11327-117E4	49.09	3.37	4.33	0.00
Adipocyte - omental, donor1	11473-119C6	56.49	2.16	2.04	2.16
Adipocyte - omental, donor2	11474-119C7	44.85	2.99	4.48	0.75
Adipocyte - omental, donor3	11475-119C8	50.57	1.67	3.68	1.34
Adipocyte - perirenal, donor1	11476-119C9	52.32	3.83	6.38	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	40.19	3.16	4.52	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	33.02	1.91	7.82	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	69.23	5.08	5.87	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	52.25	1.80	0.00	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	52.41	1.67	1.12	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	54.08	2.35	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	75.53	4.91	9.97	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	61.32	1.29	1.61	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	35.19	0.53	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	38.39	1.11	1.67	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	52.82	2.08	3.74	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	44.21	1.00	1.00	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	40.58	1.96	0.33	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	41.41	1.22	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	80.44	5.08	3.76	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	21.51	0.72	3.59	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	15.57	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	117.48	6.66	3.78	1.62
Amniotic Epithelial Cells, donor2	11613-122A2	60.25	1.67	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	72.11	3.49	8.42	0.41
Anulus Pulposus Cell, donor1	11248-116E6	47.03	1.95	3.43	1.14
Anulus Pulposus Cell, donor2	11463-119B5	62.21	2.69	1.96	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	35.94	1.80	8.09	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	43.85	2.60	8.25	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	34.24	0.00	8.56	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	40.06	3.59	9.86	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	36.67	1.26	3.79	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	26.40	0.66	7.92	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	35.09	2.27	5.85	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	35.44	1.46	6.31	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	31.48	0.00	11.88	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	33.14	2.64	7.91	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	45.72	3.63	4.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	0.00	6.27	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	43.16	1.48	5.27	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	34.12	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	35.89	1.06	11.31	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	40.72	4.29	5.36	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	51.01	3.02	15.68	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	40.36	1.07	12.30	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	28.29	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	55.73	2.32	13.27	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	22.81	1.20	7.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	7.08	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	52.49	2.06	12.69	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	46.12	1.46	8.25	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	52.36	1.52	9.87	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	29.07	0.00	9.69	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	32.49	1.14	7.41	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	48.74	1.92	8.12	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	33.04	1.03	9.55	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	40.35	1.88	6.10	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	43.41	1.29	9.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.11	2.85	6.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	39.19	2.92	8.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	41.25	0.90	9.33	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	27.32	1.19	10.69	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	37.12	4.58	9.15	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	45.84	0.76	8.15	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	28.59	0.00	8.26	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	36.25	0.86	7.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	39.80	2.54	12.91	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	30.74	0.29	8.99	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	32.12	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	46.28	2.03	11.53	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	0.00	11.58	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	41.17	1.07	8.58	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	25.27	1.80	5.41	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	35.72	0.73	13.12	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	45.06	1.84	11.26	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	45.91	0.00	7.65	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	32.80	1.27	6.10	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	47.48	2.06	6.61	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	31.21	0.31	8.57	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	51.63	1.43	12.91	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	45.23	2.00	12.20	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	38.14	1.53	10.68	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	41.54	0.55	10.52	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	42.90	1.06	6.88	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	29.08	1.09	13.08	0.73
Astrocyte - cerebellum, donor1	11500-119F6	90.27	3.81	3.56	0.74
Astrocyte - cerebellum, donor2	11580-120F5	53.40	3.42	2.91	1.37
Astrocyte - cerebellum, donor3	11661-122F5	35.24	1.47	3.15	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	97.26	5.23	16.03	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	96.58	6.96	8.90	2.59
Astrocyte - cerebral cortex, donor3	11392-118C6	101.73	6.71	9.99	2.98
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	55.51	3.10	6.19	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	59.63	4.89	7.89	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	56.22	2.50	4.67	0.23
Basophils, donor1	12241-129G9	104.35	1.05	1.05	0.00
Basophils, donor2	12242-129H1	108.24	1.44	5.77	0.36
Basophils, donor3	12243-129H2	83.64	1.76	7.35	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	60.37	3.02	0.86	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	18.29	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	7.17	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	80.97	5.02	7.53	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	112.50	4.37	7.28	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	60.80	2.76	3.45	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	64.24	2.34	17.63	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	53.07	3.50	5.56	0.72
Burkitt's lymphoma cell line:RAJI	10476-106I8	63.35	4.66	7.92	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	58.52	0.96	5.12	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	175.81	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	52.97	0.00	1.69	0.00
CD14+ Monocytes, donor2	11305-117B9	57.54	0.56	2.78	0.19
CD14+ Monocytes, donor3	11381-118B4	61.25	1.32	6.81	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	74.16	1.42	8.49	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	81.88	2.27	4.93	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	92.38	2.63	7.56	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	109.71	3.76	10.41	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	112.25	1.51	7.85	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	138.58	2.61	4.26	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	54.91	1.17	3.18	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	54.10	0.28	3.04	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	54.30	0.99	0.99	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	32.70	0.98	4.31	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	42.91	0.53	2.85	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	43.31	1.31	0.44	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	36.99	1.17	1.64	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	57.03	0.00	2.64	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	42.16	2.22	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	71.10	1.78	6.84	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	69.04	0.80	3.19	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	65.58	1.46	2.08	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	38.21	0.00	5.49	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	43.88	0.45	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	53.68	0.44	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	85.54	3.50	2.69	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	81.12	1.40	9.42	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	99.31	1.68	2.95	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	18.74	0.55	1.10	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	26.77	1.06	1.41	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	33.34	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	36.79	0.70	3.31	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	44.60	0.74	5.20	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	55.40	0.86	0.43	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	28.25	0.00	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	24.11	0.23	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	21.58	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	42.72	1.74	0.44	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	49.66	1.39	6.24	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	42.46	1.52	1.52	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	69.76	2.02	3.11	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	56.76	1.22	3.14	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	114.38	3.79	0.45	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	43.38	0.77	1.02	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	46.33	2.20	5.93	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	53.27	0.84	2.11	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	50.81	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	67.12	3.39	6.10	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	55.92	1.04	4.14	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	66.10	2.13	5.33	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	79.87	2.14	1.61	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	65.98	3.51	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	52.55	3.14	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	76.46	2.64	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	78.90	7.40	13.97	0.00
CD19+ B Cells, donor2	11624-122B4	68.92	2.18	5.08	0.73
CD19+ B Cells, donor3	11705-123B4	81.28	1.01	6.56	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	117.18	4.85	4.44	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	82.69	3.20	3.99	0.00
CD34+ Progenitors, donor1	11545-120B6	72.29	5.02	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	71.35	1.69	2.25	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	61.62	3.01	11.27	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	56.82	3.16	5.41	0.90
CD4+ T Cells, donor1	11225-116C1	62.13	0.36	3.57	0.00
CD4+ T Cells, donor2	11306-117C1	58.17	1.22	1.84	0.61
CD4+ T Cells, donor3	11382-118B5	62.22	1.22	5.79	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	45.43	1.53	0.77	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	44.02	0.67	4.49	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	45.13	1.44	6.04	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	54.52	1.42	1.90	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	65.32	0.70	4.21	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	69.22	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	40.61	1.59	3.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	39.65	1.53	8.30	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	38.21	0.81	12.57	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	32.73	1.34	4.93	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	42.28	0.70	3.49	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	51.04	0.44	5.28	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	48.07	0.84	2.11	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	36.57	1.66	7.06	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	30.07	0.67	5.01	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	53.03	0.54	2.18	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	84.14	0.54	6.97	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	64.56	3.59	10.76	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	50.07	1.67	2.23	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	40.72	1.08	5.20	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	39.51	0.63	9.67	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	40.95	0.51	0.51	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	37.26	0.87	3.47	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	71.47	2.18	3.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	74.73	0.99	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	62.78	0.92	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	55.83	0.00	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	118.25	1.94	0.83	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	120.24	2.70	1.47	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	92.40	6.16	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	70.55	2.51	1.79	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	95.56	2.77	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	63.51	1.31	1.96	0.00
CD8+ T Cells, donor2	11307-117C2	54.44	0.75	2.25	0.75
CD8+ T Cells, donor3	11383-118B6	75.75	2.02	11.87	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	21.79	0.23	2.29	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	20.13	0.72	1.92	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	14.23	0.82	1.92	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	26.42	0.60	5.70	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	25.92	1.20	5.28	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	26.15	0.91	1.82	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.47	0.43	2.82	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	26.32	1.05	4.21	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	26.50	0.23	2.11	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	20.53	0.30	2.72	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.98	2.32	3.49	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	26.38	1.07	4.26	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	30.64	0.88	4.82	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	33.70	2.73	4.55	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	23.12	1.49	4.48	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.13	1.44	4.68	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	26.18	1.44	4.89	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	21.21	1.18	5.19	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	32.32	0.95	6.65	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	27.37	0.62	7.69	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	27.57	0.64	6.41	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	29.45	1.91	4.21	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	21.28	1.18	3.15	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	25.72	0.76	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	30.51	2.41	2.41	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	31.47	4.20	3.50	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	49.09	3.01	9.02	0.00
Cardiac Myocyte, donor1	11525-119I4	177.29	9.14	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	52.37	3.46	4.94	0.99
Cardiac Myocyte, donor3	11686-122I3	60.30	2.74	12.00	0.74
Chondrocyte - de diff, donor1	11261-116G1	85.63	3.81	10.75	1.73
Chondrocyte - de diff, donor2	11338-117F6	71.79	2.84	3.20	1.78
Chondrocyte - de diff, donor3	11410-118E6	49.95	2.50	16.95	1.37
Chondrocyte - re diff, donor2	11339-117F7	161.15	7.16	2.69	1.79
Chondrocyte - re diff, donor3	11411-118E7	68.34	6.07	2.02	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	67.59	3.67	6.08	2.07
Ciliary Epithelial Cells, donor2	11323-117D9	52.16	5.13	5.99	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	60.09	3.01	7.26	1.42
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	96.47	6.42	5.41	3.30
Corneal Epithelial Cells, donor1	11526-119I5	44.57	1.98	2.42	0.66
Corneal Epithelial Cells, donor2	11606-120I4	43.23	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	49.85	2.30	4.86	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	71.16	1.65	7.10	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	69.71	2.52	7.57	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	51.73	1.84	8.75	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	63.20	1.71	4.78	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	62.02	2.61	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	91.95	0.48	1.94	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	121.24	3.84	8.51	1.33
Endothelial Cells - Aortic, donor1	11263-116G3	101.51	4.69	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	120.19	4.81	1.70	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	119.53	2.36	3.15	1.18
Endothelial Cells - Artery, donor1	11264-116G4	69.81	2.04	6.11	0.58
Endothelial Cells - Artery, donor2	11341-117F9	64.00	2.82	13.41	0.71
Endothelial Cells - Artery, donor3	11413-118E9	84.50	4.56	9.82	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	57.85	1.55	10.64	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	80.33	2.43	5.17	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	104.59	5.64	2.82	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	76.36	3.27	10.10	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	99.45	4.17	3.64	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	47.92	2.13	5.10	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	155.25	8.00	14.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	59.23	0.52	12.05	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	108.96	4.47	9.57	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	102.55	3.91	3.91	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	127.62	5.74	6.23	0.98
Endothelial Cells - Vein, donor1	11267-116G7	64.84	3.41	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	82.42	2.79	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	76.62	2.04	7.54	0.16
Eosinophils, donor1	12244-129H3	137.22	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	338.30	14.85	3.30	0.00
Eosinophils, donor3	12246-129H5	231.84	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	56.44	2.44	0.73	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	39.52	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	77.18	3.69	8.21	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	22.45	0.99	5.36	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	38.35	2.38	5.74	1.19
Fibroblast - Aortic Adventitial, donor1	11245-116E3	63.79	3.27	5.34	1.33
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	75.47	5.73	8.60	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	49.46	3.06	6.43	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	68.24	2.90	1.84	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	60.79	2.99	6.64	1.99
Fibroblast - Cardiac, donor1	11268-116G8	73.94	4.99	4.99	0.45
Fibroblast - Cardiac, donor2	11345-117G4	75.04	3.79	0.76	1.52
Fibroblast - Cardiac, donor3	11417-118F4	35.80	1.89	5.20	0.63
Fibroblast - Cardiac, donor4	11452-119A3	73.66	5.46	0.61	1.82
Fibroblast - Cardiac, donor5	11456-119A7	86.17	3.68	12.44	0.63
Fibroblast - Cardiac, donor6	11460-119B2	63.82	3.34	6.22	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	84.82	4.15	3.48	1.61
Fibroblast - Choroid Plexus, donor2	11572-120E6	60.83	3.88	5.61	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	67.38	5.86	5.86	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	65.04	2.77	0.92	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	42.40	2.54	2.71	0.51
Fibroblast - Dermal, donor1	11269-116G9	62.92	3.29	5.87	0.94
Fibroblast - Dermal, donor2	11346-117G5	61.32	3.77	2.83	0.47
Fibroblast - Dermal, donor3	11418-118F5	47.27	3.02	14.39	0.73
Fibroblast - Dermal, donor4	11450-119A1	64.66	7.46	9.16	0.90
Fibroblast - Dermal, donor5	11454-119A5	79.38	5.23	6.28	0.87
Fibroblast - Dermal, donor6	11458-119A9	90.63	8.28	8.93	1.79
Fibroblast - Gingival, donor1	11237-116D4	83.08	3.75	4.37	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	74.15	2.88	3.67	0.79
Fibroblast - Gingival, donor2	11318-117D4	60.36	3.82	4.35	0.79
Fibroblast - Gingival, donor3	11394-118C8	73.19	3.96	1.93	1.64
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	64.41	4.16	13.51	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	45.11	1.59	2.82	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	76.23	5.14	2.34	2.03
Fibroblast - Gingival, donor6 (control)	11922-125H5	73.29	4.60	1.49	1.35
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	58.58	4.23	0.35	1.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	69.61	1.32	3.36	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	68.04	2.45	1.91	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	77.11	4.94	1.86	1.54
Fibroblast - Gingival, donor9 (control)	11927-125I1	68.09	2.05	3.67	1.17
Fibroblast - Lung, donor1	11270-116H1	33.98	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	41.78	0.00	4.48	4.48
Fibroblast - Lung, donor3	11419-118F6	49.38	4.01	10.55	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	138.28	5.83	0.83	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	58.74	8.39	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	25.19	1.12	0.28	0.56
Fibroblast - Mammary, donor1	11540-120B1	127.07	6.50	1.62	1.62
Fibroblast - Mammary, donor2	11620-122A9	27.96	3.99	7.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	47.65	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	72.16	4.07	4.07	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	91.46	5.92	7.89	1.82
Fibroblast - Periodontal Ligament, donor3	11395-118C9	147.49	8.87	3.67	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	94.26	8.40	4.20	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	54.81	2.97	3.24	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	68.54	3.48	2.67	1.16
Fibroblast - Pulmonary Artery, donor1	11250-116E8	58.14	2.65	11.72	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	95.09	4.88	1.63	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	39.42	1.34	3.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	24.51	1.98	3.16	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	77.20	6.15	2.58	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	49.02	3.37	2.13	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	57.94	3.35	0.79	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	60.47	4.81	1.50	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	93.70	6.26	3.02	1.19
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	71.37	5.82	2.28	1.27
Fibroblast - skin normal, donor1	11553-120C5	67.27	3.45	1.64	1.15
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	67.57	5.41	11.43	1.20
Fibroblast - skin normal, donor2	11561-120D4	99.86	6.43	8.34	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	86.14	6.35	3.93	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	47.55	3.07	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	77.44	5.30	2.39	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	68.97	5.91	2.63	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	106.63	6.60	7.99	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	73.54	4.39	2.70	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	54.10	3.76	9.72	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	842.07	0.00	864.23	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	67.11	1.74	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	82.34	2.77	6.41	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	115.81	5.47	8.59	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	146.15	5.88	6.90	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	69.67	3.06	25.26	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	66.36	3.19	28.08	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	103.84	9.41	65.04	4.56
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	113.06	9.93	49.64	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	79.46	4.57	18.04	2.74
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	92.92	6.74	46.96	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	102.56	5.02	44.67	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	92.95	4.89	19.89	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	82.70	4.42	13.27	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	62.32	7.77	2.40	1.55
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	57.75	6.90	2.09	2.09
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	67.42	4.84	15.04	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	63.19	5.70	3.72	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	72.40	7.61	1.38	2.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	71.56	4.88	11.38	1.63
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	59.78	2.74	12.09	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	59.29	5.11	1.37	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	90.27	5.03	8.09	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	58.80	3.25	11.82	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	57.38	4.29	1.43	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	77.08	4.02	8.27	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	63.92	4.23	8.27	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	51.40	5.94	2.21	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	79.80	5.50	2.04	1.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	75.65	4.68	9.47	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	79.07	4.27	5.12	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	56.88	4.87	5.42	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	66.14	4.08	3.16	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	81.26	4.29	3.27	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	62.72	3.09	10.11	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	45.08	4.50	0.46	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	61.70	3.34	6.50	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	42.54	2.87	9.26	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	48.21	3.94	1.60	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	64.51	5.67	7.78	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	60.62	2.57	6.41	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	45.01	3.88	1.52	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	54.25	3.64	7.28	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	59.60	4.87	5.78	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	44.43	4.60	3.03	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	44.57	1.76	4.17	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	59.76	3.65	5.33	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	50.18	4.07	0.56	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	48.13	1.87	5.62	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	59.37	3.67	6.73	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	45.34	2.59	0.78	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	65.33	2.71	6.51	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	52.17	3.13	6.45	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	47.37	2.63	5.26	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	71.41	4.96	8.93	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	45.64	3.17	6.07	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	47.01	2.42	4.84	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	124.03	10.67	4.57	4.07
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	149.89	12.54	14.53	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	69.03	5.39	1.39	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	86.54	10.02	1.43	2.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	67.59	4.38	20.65	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	57.92	2.83	19.21	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	103.31	6.00	6.00	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	84.14	4.95	19.80	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	105.21	4.64	5.42	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	80.22	1.60	16.04	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	78.25	8.69	12.17	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	92.76	4.88	4.23	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	84.42	6.18	6.18	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	96.64	3.33	49.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	90.05	5.59	4.47	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	90.21	2.94	3.60	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	74.66	9.23	36.07	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	99.24	5.73	3.50	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	85.59	5.77	6.45	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	73.09	4.18	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	85.90	4.58	9.16	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	73.70	4.14	4.14	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	86.40	6.78	22.02	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	107.28	7.04	4.56	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	99.19	5.98	6.67	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	68.43	3.46	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	81.17	1.96	3.91	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	81.60	0.00	12.04	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	97.86	3.85	5.01	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	98.94	4.11	4.45	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	106.85	0.00	42.24	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	96.73	3.77	12.27	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	78.45	4.22	3.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	85.97	2.54	12.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	101.70	5.58	14.36	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	81.40	4.44	4.93	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	90.89	3.54	3.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	82.85	4.08	4.08	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	85.58	4.83	4.83	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	77.99	5.93	5.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	76.41	3.58	4.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	53.38	2.91	2.91	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	50.22	3.42	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	29.11	1.25	2.49	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	64.09	1.12	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	39.96	4.76	4.12	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	29.24	1.25	4.60	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	50.83	4.18	9.52	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	59.42	3.71	2.70	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	57.56	3.19	7.05	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	50.28	3.50	8.31	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	55.88	4.51	3.44	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	55.76	3.88	4.52	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	44.21	2.99	3.99	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	47.18	1.72	3.60	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	33.00	2.24	3.52	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	87.86	2.24	5.04	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	36.79	1.30	3.90	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	64.20	4.23	1.41	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	22.52	0.00	2.91	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	50.88	4.55	4.55	0.70
Hepatocyte, donor1	11523-119I2	60.53	2.42	2.42	1.21
Hepatocyte, donor2	11603-120I1	95.88	3.23	2.15	0.00
Hepatocyte, donor3	11684-122I1	58.90	1.84	6.14	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	41.77	0.65	3.26	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	150.66	6.64	13.11	1.40
Iris Pigment Epithelial Cells, donor1	11530-119I9	60.37	2.74	4.94	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	26.30	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	28.19	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	4.57	0.00	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	21.12	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	30.01	0.00	3.33	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	30.44	3.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	27.72	3.33	0.00	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	13.86	2.52	0.63	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	27.84	3.09	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	13.57	3.23	0.00	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	27.37	1.61	0.00	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	21.19	1.63	0.00	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	11.75	0.00	0.84	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.88	2.41	0.00	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	26.78	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	19.83	1.89	0.94	2.36
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	14.51	0.91	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	18.29	3.23	0.00	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	21.60	1.27	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	17.22	1.28	0.64	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	41.92	3.65	0.00	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	14.28	0.00	0.00	3.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	14.20	2.16	0.93	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	8.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	24.34	2.78	0.00	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	2.21	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	3.24	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.95	0.87	0.87	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	29.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	14.93	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	27.71	2.77	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	21.17	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	0.00	3.03	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	65.85	1.55	1.96	1.06
Keratinocyte - epidermal, donor2	11349-117G8	42.17	2.93	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	90.40	2.93	10.89	1.23
Keratinocyte - oral, donor1	11251-116E9	110.00	4.09	15.44	0.91
Keratocytes, donor1	11527-119I6	95.93	3.78	2.75	1.38
Keratocytes, donor2	11607-120I5	45.70	3.52	7.03	0.00
Keratocytes, donor3	11688-122I5	50.98	2.37	5.34	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	83.52	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	60.41	6.47	8.63	1.08
Lens Epithelial Cells, donor2	11609-120I7	91.34	5.31	12.11	1.04
Lens Epithelial Cells, donor3	11690-122I7	104.95	5.45	1.11	2.62
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	58.34	2.37	8.42	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	27.35	1.67	6.14	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	52.89	2.20	10.07	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	37.10	1.08	6.99	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	32.78	1.58	3.47	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	30.94	1.73	5.50	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	39.40	1.64	9.03	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	20.48	0.76	3.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	35.75	1.13	5.63	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	43.90	1.19	9.49	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	28.31	2.52	6.59	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	17.77	0.56	1.30	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	40.42	0.70	12.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	34.11	0.24	6.20	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	29.94	1.10	2.47	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	40.65	1.23	12.63	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	21.20	0.62	5.92	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	33.67	0.91	4.21	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	33.24	0.33	9.54	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	15.23	0.88	2.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	21.91	1.49	1.99	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	32.49	1.94	8.73	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	31.78	0.81	7.27	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	37.69	2.27	6.36	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	25.92	0.00	6.22	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	34.13	0.84	7.75	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	30.22	0.90	3.76	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	28.20	2.06	17.88	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	33.68	1.51	10.54	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	30.01	1.38	4.14	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	44.10	0.97	9.21	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	26.79	0.33	6.28	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	26.51	0.99	3.84	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	47.76	2.22	10.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	30.64	0.74	4.94	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	21.17	0.96	4.54	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	45.99	0.96	7.40	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	39.87	0.91	8.83	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	42.69	2.10	6.02	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	41.60	1.42	17.07	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	25.21	0.48	2.91	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	19.61	0.47	2.96	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	37.96	0.36	13.61	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	33.65	1.63	4.57	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	21.89	0.71	2.83	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	57.79	2.35	6.31	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	22.80	0.77	3.84	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	38.19	1.49	4.77	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	31.72	0.00	0.00	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	29.15	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	23.75	2.97	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	17.77	0.85	0.42	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	23.21	2.11	4.22	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	24.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	19.06	0.00	1.03	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	20.22	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	19.90	2.04	0.23	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	27.05	1.45	4.07	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	25.21	0.90	1.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	24.79	1.49	0.68	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	25.68	1.54	2.57	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	32.46	1.76	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	22.65	0.67	2.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.51	1.02	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	33.62	3.47	1.87	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	32.69	1.51	1.89	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	25.77	0.61	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	44.85	1.63	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	29.78	2.08	4.16	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	21.86	0.56	3.64	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	42.24	1.03	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	31.93	1.74	2.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	28.10	0.60	1.79	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	30.43	1.66	2.77	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	26.87	1.41	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	22.86	1.48	1.48	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	25.33	2.30	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	25.71	1.92	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	26.61	1.13	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	35.28	1.64	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	27.56	0.90	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.95	1.44	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	29.88	1.49	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	22.30	1.86	1.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	30.58	0.43	3.02	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	31.68	2.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	22.66	0.33	1.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	36.20	1.21	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	27.02	2.13	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.94	1.03	1.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	28.98	0.00	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	19.53	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.19	0.37	2.22	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	26.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	20.10	0.00	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	28.41	1.60	1.20	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	26.89	0.73	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	41.39	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	32.56	0.49	1.97	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.00	1.88	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	25.64	1.01	1.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	25.23	0.90	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	34.74	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	28.15	0.39	0.78	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	26.39	0.66	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	38.40	1.04	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	37.19	1.75	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	33.55	1.68	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	36.21	1.32	3.09	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	28.93	1.93	1.54	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	29.87	1.01	1.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	38.45	1.92	1.92	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	28.23	2.78	1.99	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	37.67	0.00	2.43	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.22	0.69	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	30.02	0.76	1.90	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	27.89	1.03	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	31.44	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	32.64	2.22	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	21.86	0.53	2.67	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	23.56	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	28.80	2.06	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	32.54	1.41	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	31.21	3.40	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	32.03	1.66	0.83	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	36.80	1.57	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.23	2.09	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	35.31	0.93	0.93	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.08	1.34	2.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	43.31	2.14	0.53	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	25.86	2.83	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	20.19	1.84	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	25.78	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	30.20	2.85	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	29.14	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	30.09	1.09	1.09	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	25.39	0.45	1.34	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	27.04	1.82	0.52	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.88	1.99	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	43.65	4.16	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	56.98	3.42	7.29	0.91
Macrophage - monocyte derived, donor2	11313-117C8	56.15	1.65	8.07	0.55
Macrophage - monocyte derived, donor3	11389-118C3	62.00	2.49	3.54	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	82.31	3.19	3.19	0.53
Mallassez-derived cells, donor2	11929-125I3	123.28	6.34	1.27	0.48
Mallassez-derived cells, donor3	11930-125I4	120.92	5.42	1.53	0.56
Mammary Epithelial Cell, donor1	11273-116H4	78.02	2.89	6.58	2.69
Mammary Epithelial Cell, donor2	11350-117G9	75.28	4.92	6.37	1.16
Mammary Epithelial Cell, donor3	11422-118F9	55.12	2.49	3.74	0.75
Mast cell - stimulated, donor1	11487-119E2	215.58	3.39	2.03	2.03
Mast cell, donor1	11563-120D6	82.08	2.70	10.06	0.43
Mast cell, donor2	11565-120D8	116.79	2.97	6.84	0.89
Mast cell, donor3	11566-120D9	119.32	3.38	2.25	0.23
Mast cell, donor4	11567-120E1	107.26	4.61	7.27	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	69.53	1.66	4.21	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	47.28	1.17	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	50.94	1.26	4.13	0.57
Mast cell, expanded, donor8	11941-126A6	45.02	1.51	1.51	0.33
Melanocyte - dark, donor1	11502-119F8	86.17	4.18	10.65	0.80
Melanocyte - dark, donor2	11582-120F7	51.22	2.08	5.88	0.00
Melanocyte - dark, donor3	11663-122F7	83.60	6.23	4.85	1.23
Melanocyte - light, donor1	11274-116H5	50.78	2.82	0.71	1.18
Melanocyte - light, donor2	11351-117H1	45.04	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	27.75	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	45.61	3.44	3.44	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	50.02	1.61	4.30	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	67.23	1.61	4.55	0.54
Meningeal Cells, donor1	11493-119E8	118.60	5.71	2.73	2.48
Meningeal Cells, donor2	11573-120E7	111.36	4.40	1.32	2.20
Meningeal Cells, donor3	11654-122E7	61.78	2.85	2.93	1.47
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	51.61	4.28	19.39	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	46.89	1.81	2.92	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	17.01	0.00	5.23	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	40.90	5.02	8.61	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	43.20	1.69	2.54	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	47.25	1.01	5.53	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	50.32	1.98	1.10	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	51.14	1.46	5.84	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	40.72	2.05	3.07	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	53.33	1.66	0.69	1.25
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	20.82	1.49	0.74	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	40.00	1.97	5.53	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	25.82	0.89	0.59	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	50.59	3.20	1.92	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	60.26	4.61	13.82	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	48.47	2.81	9.38	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	60.96	4.35	2.90	1.45
Mesothelial Cells, donor1	11247-116E5	68.68	3.18	13.79	0.80
Mesothelial Cells, donor2	12156-128G5	89.58	3.00	2.50	3.50
Mesothelial Cells, donor3	11402-118D7	77.47	2.96	10.04	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	48.61	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	64.77	3.69	3.94	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	42.40	2.06	1.77	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	34.57	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	55.17	2.48	2.79	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	32.77	0.41	2.28	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	58.56	1.00	5.26	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	48.41	0.93	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	50.60	1.42	2.44	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	39.20	1.98	2.38	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	36.28	2.65	3.54	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.77	0.76	3.04	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	28.95	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	29.50	1.06	2.55	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	24.86	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	33.38	1.49	2.09	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	26.83	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	30.61	1.76	3.01	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	30.42	0.71	0.95	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	37.04	0.55	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	36.38	1.15	0.92	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	33.02	1.47	1.05	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	32.61	1.43	1.22	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	36.47	1.50	2.15	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	45.35	1.33	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	41.61	0.66	2.19	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	33.46	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	33.14	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	57.35	1.36	1.90	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	41.47	0.59	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	40.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	48.54	1.92	1.92	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	44.83	0.40	1.60	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	47.99	0.00	8.23	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	53.56	1.50	2.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	34.65	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	45.98	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	68.43	1.10	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	68.52	1.92	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	64.95	1.74	1.74	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	66.11	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	50.83	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	45.47	1.71	4.44	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	61.27	2.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	36.57	0.71	1.42	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	47.69	1.12	6.73	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	64.84	2.08	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	69.93	1.17	0.00	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	48.87	1.21	2.71	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	65.53	2.09	1.25	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	14.44	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	55.41	1.85	3.69	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	71.71	2.28	2.85	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	44.49	2.07	0.97	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	50.02	2.07	3.11	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	62.20	1.72	1.72	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	47.00	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	68.32	1.60	1.07	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	79.92	2.39	2.99	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	33.90	0.85	0.42	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	42.04	1.91	1.27	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	66.56	1.99	2.21	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	56.12	1.14	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	59.38	1.14	2.84	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	58.26	0.74	2.46	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	61.26	2.61	2.61	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	59.98	1.47	3.53	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	65.74	1.73	3.46	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	58.94	0.41	1.65	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	54.49	0.89	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	37.43	0.00	3.56	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	53.56	0.99	6.24	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	31.56	3.16	5.26	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	42.70	0.79	5.93	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	94.06	2.79	4.66	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	61.21	1.50	7.14	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	47.68	1.07	5.06	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	41.62	1.70	1.13	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	41.99	0.00	3.68	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	48.37	2.20	5.50	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	31.11	0.00	12.44	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	45.96	1.60	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	44.44	1.01	7.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	35.00	1.69	4.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	34.05	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.99	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.96	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	22.66	0.00	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	142.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	68.51	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	100.39	0.00	12.55	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	67.86	3.02	2.15	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	52.26	3.14	6.79	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	31.37	1.33	4.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	35.48	3.76	4.59	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	58.94	3.99	7.04	1.33
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	143.63	12.77	4.79	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	26.52	0.68	1.36	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	203.98	7.35	58.80	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	28.88	1.26	0.00	2.09
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	43.93	2.56	2.79	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	34.59	2.16	2.43	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	75.26	2.73	6.52	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	378.58	22.27	334.04	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	25.31	1.49	5.46	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	29.50	1.35	5.14	2.17
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	30.15	0.91	5.44	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	28.74	1.47	2.12	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	59.42	2.55	9.30	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	24.40	1.06	2.12	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	22.21	0.00	1.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	43.98	1.97	6.89	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	31.06	2.28	2.44	1.14
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	68.08	2.29	7.58	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.88	1.41	2.11	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	28.04	1.84	2.30	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	34.71	1.61	3.53	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	48.28	2.41	13.80	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	265.49	42.98	25.28	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	65.94	2.01	3.12	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	25.40	1.27	3.39	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	22.07	1.19	1.19	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	39.92	1.29	3.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	695.14	27.08	234.72	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	46.65	2.67	2.67	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	51.40	2.25	5.41	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	23.81	1.59	2.78	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	32.50	0.93	0.93	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	30.65	1.51	1.89	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	35.52	2.28	3.26	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	31.38	2.61	1.74	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	86.39	1.81	4.98	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.93	0.88	4.41	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	21.94	1.33	2.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	47.12	3.47	2.48	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	37.52	1.53	2.30	1.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	32.36	1.21	4.84	1.51
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	72.50	3.09	8.18	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	27.78	2.71	3.39	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	194.16	0.00	71.53	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	42.68	5.49	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	42.49	1.57	3.15	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	31.78	1.51	3.93	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	30.85	0.00	7.91	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	45.35	1.13	13.60	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	182.08	20.23	80.93	5.06
Myoblast, donor1	11241-116D8	63.36	3.11	8.32	0.99
Myoblast, donor2	11322-117D8	63.87	4.41	2.88	1.73
Myoblast, donor3	11398-118D3	81.73	5.38	9.42	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	61.29	1.90	6.28	0.88
Natural Killer Cells, donor1	11230-116C6	64.58	1.54	4.00	0.62
Natural Killer Cells, donor2	11311-117C6	49.76	0.90	3.62	0.00
Natural Killer Cells, donor3	11387-118C1	59.82	1.66	9.75	0.00
Neural stem cells, donor1	11275-116H6	113.96	7.26	5.08	2.54
Neural stem cells, donor2	11352-117H2	194.49	13.48	1.93	0.00
Neurons, donor1	11494-119E9	112.65	13.65	9.10	0.00
Neurons, donor2	11574-120E8	120.43	6.38	22.46	0.44
Neurons, donor3	11655-122E8	99.48	3.29	38.64	0.00
Neutrophils, donor1	11233-116C9	258.91	3.71	19.49	1.86
Neutrophils, donor2	11314-117C9	156.54	2.90	26.09	0.00
Neutrophils, donor3	11390-118C4	394.60	8.55	2.44	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	65.66	3.21	5.46	2.49
Nucleus Pulposus Cell, donor2	11409-118E5	31.58	1.30	2.93	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	59.76	3.61	3.21	0.60
Olfactory epithelial cells, donor1	11933-125I7	46.25	2.06	9.64	0.55
Olfactory epithelial cells, donor2	11934-125I8	63.11	1.74	17.37	1.59
Olfactory epithelial cells, donor3	11935-125I9	47.67	2.50	8.97	1.14
Olfactory epithelial cells, donor4	11936-126A1	79.67	1.95	4.97	1.07
Oligodendrocyte - precursors, donor1	11496-119F2	97.49	5.42	5.42	1.81
Osteoblast - differentiated, donor1	11276-116H7	51.05	3.19	1.70	0.64
Osteoblast - differentiated, donor2	11353-117H3	25.15	0.00	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	38.48	0.62	2.48	0.00
Osteoblast, donor1	11277-116H8	40.46	4.30	1.56	0.98
Osteoblast, donor2	11354-117H4	81.47	4.21	10.53	2.81
Osteoblast, donor3	11426-118G4	105.75	6.58	1.78	0.89
Pancreatic stromal cells, donor1	11249-116E7	45.66	3.54	5.90	0.84
Pericytes, donor1	11491-119E6	27.15	1.78	0.89	0.78
Pericytes, donor2	11571-120E5	36.67	3.17	3.62	0.91
Pericytes, donor3	11652-122E5	45.37	1.83	5.09	1.42
Perineurial Cells, donor1	11499-119F5	51.20	3.05	5.99	1.02
Perineurial Cells, donor2	11579-120F4	72.23	5.34	4.23	1.38
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	83.51	0.64	1.91	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	49.95	1.47	2.94	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	58.88	2.46	1.94	0.13
Placental Epithelial Cells, donor1	11278-116H9	28.94	0.24	3.59	0.24
Placental Epithelial Cells, donor2	11355-117H5	58.77	2.22	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	40.64	1.57	4.91	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	30.70	2.22	4.11	0.32
Preadipocyte - breast, donor1	11467-119B9	46.33	3.19	1.69	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	69.05	4.96	5.09	0.91
Preadipocyte - breast, donor2	11328-117E5	50.43	4.28	5.85	0.68
Preadipocyte - omental, donor1	11468-119C1	57.86	2.77	1.39	1.39
Preadipocyte - omental, donor2	11329-117E6	73.33	5.67	6.11	1.75
Preadipocyte - omental, donor3	11403-118D8	77.78	5.59	9.17	2.15
Preadipocyte - perirenal, donor1	11469-119C2	58.07	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	50.67	2.76	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	63.57	4.96	8.68	1.95
Preadipocyte - subcutaneous, donor3	11428-118G6	52.28	4.26	8.17	1.02
Preadipocyte - visceral, donor1	11280-116I2	68.93	3.63	5.12	0.56
Preadipocyte - visceral, donor2	11357-117H7	54.30	2.30	3.68	2.30
Preadipocyte - visceral, donor3	11429-118G7	52.35	4.28	8.99	0.94
Prostate Epithelial Cells (polarized), donor1	11253-116F2	133.05	6.49	12.82	1.96
Prostate Epithelial Cells, donor2	11331-117E8	89.64	3.66	5.15	0.81
Prostate Epithelial Cells, donor3	11404-118D9	85.79	2.20	15.92	0.31
Prostate Stromal Cells, donor1	11254-116F3	60.25	3.87	8.77	0.57
Prostate Stromal Cells, donor2	11332-117E9	50.20	1.79	7.53	1.08
Prostate Stromal Cells, donor3	11405-118E1	36.71	1.36	3.65	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	47.45	3.28	1.09	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	44.29	2.36	2.08	0.35
Renal Epithelial Cells, donor1	11517-119H5	39.56	3.04	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	44.81	2.13	3.56	1.42
Renal Epithelial Cells, donor3	11678-122H4	60.77	3.28	2.75	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	76.26	2.04	2.04	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	78.03	3.64	4.45	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	96.80	5.33	2.89	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	12.64	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	52.60	1.76	0.88	0.22
Renal Mesangial Cells, donor2	11598-120H5	57.06	6.27	2.51	1.88
Renal Mesangial Cells, donor3	11679-122H5	21.08	2.22	1.94	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	79.45	4.29	2.95	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	52.29	0.84	8.01	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	49.37	3.28	2.70	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	59.38	2.07	12.19	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	62.53	3.98	2.27	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	33.96	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	39.64	0.50	1.00	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	76.84	2.94	5.08	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	46.46	3.57	2.68	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	36.87	2.20	5.50	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	54.53	1.16	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	100.90	7.02	2.34	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	51.94	3.08	4.97	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	55.10	5.58	1.23	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	81.50	6.70	2.85	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	53.14	4.55	6.76	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	61.48	3.24	9.71	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	77.08	6.98	1.37	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	46.89	4.54	4.99	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	51.43	3.94	2.15	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	65.99	5.45	2.15	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	53.12	2.58	5.58	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	52.22	5.09	6.86	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	78.00	5.35	1.15	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	60.09	4.10	4.01	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	53.55	3.01	0.75	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	89.31	4.78	1.06	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	56.26	3.31	3.21	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	59.01	3.82	8.21	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	70.38	5.98	1.60	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	46.25	0.84	4.48	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	50.76	5.30	0.85	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	76.03	4.56	1.64	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	47.95	4.54	5.76	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	50.24	3.49	6.18	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	65.34	3.77	1.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	54.76	5.36	6.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	50.04	3.04	6.31	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	65.73	5.18	2.07	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	57.51	2.43	1.11	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	57.03	4.39	4.60	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	77.52	5.52	2.96	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	64.54	4.60	2.04	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	58.42	4.63	6.17	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	80.12	2.24	2.41	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	70.23	4.80	2.61	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	54.67	3.28	4.60	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	69.71	4.77	2.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	59.92	3.26	5.47	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	55.98	4.00	3.47	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	66.92	5.53	1.52	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	49.05	3.33	6.67	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	65.90	5.64	3.22	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	50.19	4.05	1.41	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	48.91	4.19	5.94	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	56.82	1.51	1.51	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	51.52	2.94	0.98	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	52.98	4.66	0.87	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	51.11	2.43	6.69	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	50.03	1.51	2.41	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	41.84	3.39	6.56	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	49.12	3.00	5.69	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	56.68	3.90	1.42	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	45.89	2.13	3.84	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	56.49	4.21	4.81	0.00
Schwann Cells, donor1	11498-119F4	39.49	2.44	4.14	1.50
Schwann Cells, donor2	11578-120F3	64.65	0.00	6.80	0.00
Schwann Cells, donor3	11659-122F3	52.14	2.19	1.53	0.22
Sebocyte, donor1	11220-116B5	159.40	10.96	8.76	2.74
Sebocyte, donor2	11301-117B5	73.07	4.60	1.38	0.46
Sebocyte, donor3	11378-118B1	45.76	4.12	2.89	0.41
Sertoli Cells, donor1	11255-116F4	101.05	1.66	24.85	0.00
Sertoli Cells, donor2	11333-117F1	48.01	2.82	8.47	0.00
Skeletal Muscle Cells, donor1	11281-116I3	61.41	2.38	1.41	0.53
Skeletal Muscle Cells, donor2	11358-117H8	20.96	0.00	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	63.54	3.34	5.85	0.00
Skeletal Muscle Cells, donor4	11451-119A2	66.92	5.34	8.95	2.04
Skeletal Muscle Cells, donor5	11455-119A6	56.63	2.97	8.47	1.49
Skeletal Muscle Cells, donor6	11459-119B1	79.88	7.70	9.39	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	54.06	2.14	6.43	1.39
Skeletal Muscle Satellite Cells, donor2	11321-117D7	47.94	3.42	7.28	1.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	75.40	4.27	11.41	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	49.03	2.36	2.11	1.01
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	54.28	1.45	2.17	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	50.77	1.93	3.16	0.83
Skin - palm, donor1	10286-104F7	169.22	5.37	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	57.66	0.72	4.32	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	220.01	5.73	4.09	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	47.00	2.21	5.71	1.04
Small Airway Epithelial Cells, donor1	11256-116F5	86.32	1.67	2.36	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	102.82	3.09	4.64	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	152.88	7.40	11.42	1.90
Small Airway Epithelial Cells, donor3	11406-118E2	95.11	2.10	9.82	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	84.55	2.78	0.31	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	71.37	3.33	1.78	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	65.25	2.94	2.35	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	59.67	1.99	2.87	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	70.88	2.76	4.33	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	74.94	3.86	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	29.02	3.00	2.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	70.26	4.52	5.72	2.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	51.20	3.55	11.30	2.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	187.95	11.14	6.27	4.35
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	30.61	1.30	4.23	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	60.84	5.32	8.86	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	48.97	3.70	5.41	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	40.67	2.60	0.16	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	60.28	1.83	0.00	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	46.72	4.04	3.54	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	69.14	2.38	1.43	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	32.74	2.06	1.62	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	45.63	2.80	2.58	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	46.18	3.25	10.60	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	62.95	2.94	5.57	0.93
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	75.45	6.47	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	98.32	6.87	6.28	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	30.38	1.71	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	44.13	1.49	1.88	0.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	61.39	4.23	3.62	1.61
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	81.46	2.50	12.06	1.82
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	71.25	4.83	1.21	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	86.37	6.62	14.04	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	72.44	4.93	5.33	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	46.08	2.63	8.14	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	33.48	2.28	2.54	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	72.07	4.22	3.92	2.26
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	47.26	3.00	7.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	139.56	12.92	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	63.71	3.72	0.00	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	66.64	1.51	11.61	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	85.24	3.76	13.79	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.07	1.47	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	104.38	7.58	4.67	2.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	33.64	2.34	2.34	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	75.99	3.60	5.18	2.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	63.74	3.31	9.18	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	62.99	4.89	5.83	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	74.48	3.49	9.78	1.12
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	56.05	3.27	8.97	0.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	11.43	0.95	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	85.39	3.43	5.87	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	69.82	5.74	7.29	1.33
Smooth Muscle Cells - Uterine, donor3	11466-119B8	33.94	1.17	4.68	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	34.40	0.78	1.36	1.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	38.08	1.32	1.85	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	32.36	1.12	1.49	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	57.13	2.16	3.23	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	45.71	0.28	2.84	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	56.32	0.39	4.73	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	32.00	1.02	1.27	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	38.33	0.80	4.39	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	27.17	1.25	3.34	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	31.17	0.92	3.67	0.46
Synoviocyte, donor1	11291-117A4	44.61	1.18	3.20	1.01
Synoviocyte, donor2	11368-117I9	61.35	1.84	11.23	0.84
Synoviocyte, donor3	11440-118H9	44.46	2.23	11.62	1.56
Trabecular Meshwork Cells, donor1	11532-120A2	76.11	3.57	0.36	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	26.86	1.39	2.55	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	73.98	2.65	8.67	0.72
Tracheal Epithelial Cells, donor2	11369-118A1	49.09	1.93	1.55	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	57.27	0.57	2.86	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	76.28	3.08	7.63	1.11
Urethra, donor2	10319-105A4	97.12	3.60	5.40	1.80
Urothelial Cells, donor1	11520-119H8	89.26	2.39	3.19	0.27
Urothelial Cells, donor2	11600-120H7	52.07	2.80	4.41	0.80
Urothelial Cells, donor3	11681-122H7	49.05	2.06	3.67	0.46
Urothelial cells, donor0	11216-116B1	108.77	3.57	23.40	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	116.56	5.34	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	142.96	4.29	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	56.82	1.37	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	56.82	1.72	3.10	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	65.66	1.74	2.32	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	132.24	2.08	4.16	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	96.37	5.51	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	50.21	0.00	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	86.23	5.06	15.54	1.73
Wilms' tumor cell line:HFWT	10597-108E3	130.25	3.52	1.76	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	61.17	2.79	1.96	0.00
achilles tendon, donor2	10292-104G4	55.80	8.27	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	43.60	4.84	6.37	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	60.37	2.09	6.04	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	63.15	3.68	6.77	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	59.59	1.90	3.54	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	68.02	2.53	1.12	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	54.35	1.06	2.54	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	135.56	4.08	7.08	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	68.30	3.08	2.20	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	64.11	2.45	2.04	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	78.05	2.72	10.87	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	48.58	2.76	5.89	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	105.31	0.00	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	94.58	3.49	3.72	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	111.85	3.62	3.37	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	75.98	1.75	5.84	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	78.54	0.46	3.25	2.79
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	62.10	1.65	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	54.33	1.84	2.46	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	59.31	1.71	2.99	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	62.48	1.82	4.25	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	69.56	2.65	2.65	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	63.26	1.78	6.01	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	61.04	1.33	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	48.31	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	145.01	5.27	12.81	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	77.20	1.31	1.31	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	99.35	7.50	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	93.96	3.30	0.47	0.71
adipose tissue, adult, pool1	10010-101C1	69.96	2.95	2.02	0.62
adipose, donor1	10184-103D4	191.76	10.56	117.87	0.00
adipose, donor2	10185-103D5	64.48	2.03	28.39	1.22
adipose, donor3	10186-103D6	76.24	3.54	26.68	1.63
adipose, donor4	10187-103D7	66.74	1.73	4.33	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	130.36	6.63	6.63	3.16
adrenal gland, adult, pool1	10081-102A9	72.75	7.28	10.91	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	33.75	1.73	3.20	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	79.32	2.14	28.94	0.71
amniotic membrane cells, donor1	12235-129G3	117.08	5.56	9.97	0.46
amniotic membrane cells, donor2	12236-129G4	98.39	5.75	7.44	1.69
amniotic membrane cells, donor3	12237-129G5	98.99	5.30	4.12	0.88
amygdala - adult, donor10196	10167-103B5	160.08	11.86	23.72	4.74
amygdala, adult, donor10252	10151-102I7	143.15	8.72	14.60	1.82
amygdala, newborn, donor10223	10360-105E9	77.14	2.90	12.91	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	58.83	2.67	2.55	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	69.50	6.18	9.93	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	141.97	9.02	22.05	1.00
aorta, adult, pool1	10052-101G7	72.96	4.51	12.55	0.98
appendix, adult	10189-103D9	80.73	3.88	5.43	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	59.16	4.47	7.22	0.69
artery, adult	10190-103E1	42.12	0.00	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	123.28	5.36	2.90	1.59
b cell line:RPMI1788	10427-106D4	43.72	1.19	4.76	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	77.96	3.05	11.10	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	121.86	6.85	9.53	1.19
bile duct carcinoma cell line:TFK-1	10496-107C1	65.95	2.01	12.72	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	59.84	1.12	8.95	0.00
bladder, adult, pool1	10011-101C2	53.99	2.82	0.65	0.87
blood, adult, pool1	10053-101G8	42.08	0.00	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	94.20	4.28	0.00	1.71
bone marrow, adult	10192-103E3	55.34	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	100.46	16.40	33.83	2.05
brain, adult, pool1	10012-101C3	142.43	11.58	15.59	5.68
brain, fetal, pool1	10085-102B4	112.20	10.69	16.03	0.00
breast carcinoma cell line:MCF7	10482-107A5	73.34	1.65	0.66	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	84.63	2.75	2.75	1.00
breast, adult, donor1	10080-102A8	106.07	3.16	6.94	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	98.58	3.30	13.97	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	94.00	3.71	12.37	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	152.87	8.29	16.35	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	73.84	2.42	8.72	0.73
carcinoid cell line:NCI-H1770	10703-109H1	78.99	4.70	14.11	0.47
carcinoid cell line:NCI-H727	10735-110B6	213.07	8.42	5.58	1.53
carcinoid cell line:SK-PN-DW	10719-109I8	29.15	0.63	8.24	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	93.69	3.46	4.26	1.33
caudate nucleus - adult, donor10196	10177-103C6	177.30	6.91	21.88	2.30
caudate nucleus, adult, donor10252	10164-103B2	137.21	5.69	8.70	0.50
caudate nucleus, adult, donor10258	10379-105H1	84.06	2.29	0.76	4.58
caudate nucleus, newborn, donor10223	10354-105E3	54.93	2.20	8.79	2.20
cerebellum - adult, donor10196	10173-103C2	364.16	8.74	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	174.44	5.76	11.96	1.28
cerebellum, adult, pool1	10083-102B2	122.80	10.00	21.73	0.69
cerebellum, newborn, donor10223	10357-105E6	84.69	0.83	8.30	2.49
cerebral meninges, adult	10188-103D8	123.04	11.85	6.30	1.26
cerebrospinal fluid, donor2	10294-104G6	66.51	2.19	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	57.23	2.59	3.88	1.15
cervical cancer cell line:ME-180	10553-107I4	74.57	2.65	7.79	0.50
cervix, adult, pool1	10013-101C4	81.47	4.51	2.94	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	77.05	4.88	4.32	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	86.21	3.92	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	52.32	4.60	2.61	0.62
choriocarcinoma cell line:SCH	10785-110H2	66.41	1.36	8.01	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	63.56	3.79	1.19	0.24
chorionic membrane cells, donor1	12238-129G6	102.57	5.41	10.83	0.00
chorionic membrane cells, donor2	12239-129G7	101.42	7.06	10.54	0.80
chorionic membrane cells, donor3	12240-129G8	142.87	9.89	4.40	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	36.35	0.00	3.03	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	70.50	2.88	14.60	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	136.22	6.34	6.34	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	63.43	3.85	0.51	1.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	78.37	5.08	1.45	1.45
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	68.01	4.48	2.85	2.65
chronic myelogenous leukemia cell line:K562	10454-106G4	68.02	4.12	2.65	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	146.99	5.99	11.21	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	61.26	4.34	12.80	0.00
clear cell carcinoma cell line:TEN	10636-108I6	71.66	3.30	4.68	0.35
colon carcinoma cell line:CACO-2	10513-107D9	120.99	8.05	13.36	0.92
colon carcinoma cell line:COLO-320	10420-106C6	77.16	6.46	14.82	0.38
colon, adult, donor1	10082-102B1	96.39	3.57	11.90	0.00
colon, adult, pool1	10014-101C5	66.62	3.29	4.82	0.94
colon, fetal, donor1	10070-101I7	70.45	2.47	6.18	0.62
common myeloid progenitor CMP, donor1	12130-128D6	206.26	4.58	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	43.77	1.27	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	27.02	1.36	0.60	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	34.55	1.41	0.99	0.56
corpus callosum, adult, pool1	10042-101F6	188.18	10.72	6.63	10.72
cruciate ligament, donor2	10295-104G7	89.15	3.24	4.86	0.00
diaphragm, fetal, donor1	10069-101I6	48.96	5.62	7.22	0.00
diencephalon, adult	10193-103E4	131.75	9.60	9.60	6.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	45.92	2.30	5.97	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	107.19	4.10	2.05	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	43.81	2.65	7.94	1.44
ductus deferens, adult	10196-103E7	59.30	3.49	8.97	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	47.53	5.76	17.28	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	44.87	1.47	2.21	1.47
dura mater, adult, donor1	10041-101F5	93.98	3.22	2.31	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	24.87	1.11	1.33	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	50.87	3.01	3.30	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	66.59	1.23	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	65.08	1.82	6.96	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	76.88	0.62	3.40	0.00
embryonic pancreas cell line:2C6	10603-108E9	89.32	3.94	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	97.88	6.70	5.36	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	110.73	2.72	3.62	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	60.95	2.41	2.09	0.00
epidermoid carcinoma cell line:A431	10426-106D3	51.24	3.78	1.78	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	57.63	2.86	4.29	0.77
epididymis, adult	10197-103E8	63.84	3.98	3.77	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	100.41	7.81	8.52	4.26
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	42.86	1.57	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	48.36	3.54	5.24	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	43.60	2.56	5.61	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	53.66	2.80	7.95	0.56
esophagus, adult, pool1	10015-101C6	55.85	3.82	1.49	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	98.94	3.51	2.88	2.76
eye - muscle inferior rectus, donor1	10272-104E2	86.92	0.00	4.83	4.83
eye - muscle lateral, donor2	10298-104H1	63.13	2.10	4.21	0.00
eye - muscle medial, donor2	10299-104H2	83.34	2.98	11.91	0.00
eye - muscle superior, donor2	10297-104G9	89.43	6.88	4.59	0.00
eye - vitreous humor, donor1	10268-104D7	80.16	4.37	2.91	0.00
eye, fetal, donor1	10054-101G9	82.12	4.07	6.36	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	62.32	2.95	10.13	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	153.14	8.31	11.87	0.71
frontal lobe, adult, pool1	10040-101F4	143.55	14.45	6.57	3.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	106.59	5.70	12.31	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	119.87	5.76	2.93	0.91
gall bladder, adult	10198-103E9	63.01	2.41	1.21	0.48
gamma delta positive T cells, donor1	11937-126A2	48.85	0.54	1.61	0.54
gamma delta positive T cells, donor2	11938-126A3	48.18	2.24	7.84	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	91.25	3.80	6.55	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	204.25	7.35	5.22	0.97
gastric cancer cell line:AZ521	10549-107H9	107.39	7.54	13.12	1.80
gastric cancer cell line:GSS	10560-108A2	77.79	6.41	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	56.20	2.06	3.20	0.46
giant cell carcinoma cell line:LU65	10487-107B1	37.41	1.38	2.75	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	60.32	4.62	5.46	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	58.61	2.49	2.00	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	37.79	2.43	2.32	0.95
glioblastoma cell line:A172, tech_rep2	10444-106F3	44.10	3.37	1.97	0.56
glioblastoma cell line:T98G	10485-107A8	79.91	4.08	6.62	0.88
glioma cell line:GI-1	10413-106B8	47.45	3.22	3.51	1.17
globus pallidus - adult, donor10196	10175-103C4	214.30	8.75	12.39	1.46
globus pallidus, adult, donor10252	10161-103A8	176.97	8.54	17.57	8.30
globus pallidus, adult, donor10258	10367-105F7	130.07	8.22	57.51	2.74
globus pallidus, newborn, donor10223	10364-105F4	47.43	1.07	9.59	3.20
granulocyte macrophage progenitor, donor1	12131-128D7	208.01	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	10.45	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	90.56	3.52	5.44	0.64
hIPS +CCl2, biol_rep1	14383-156B9	130.85	6.43	3.21	2.30
hIPS +CCl2, biol_rep2	14384-156C1	118.43	5.94	3.20	1.37
hIPS +CCl2, biol_rep3	14385-156C2	136.55	5.15	3.22	4.51
hIPS, biol_rep1	14380-156B6	172.47	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	133.74	8.23	1.37	0.00
hIPS, biol_rep3	14382-156B8	164.42	13.24	3.31	3.31
hairy cell leukemia cell line:Mo	10712-109I1	41.09	3.16	9.19	1.15
heart - mitral valve, adult	10205-103F7	80.12	6.58	3.89	0.90
heart - pulmonic valve, adult	10206-103F8	67.72	3.92	5.75	0.78
heart - tricuspid valve, adult	10207-103F9	114.90	5.00	9.16	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	87.74	3.88	13.06	0.00
heart, adult, diseased, donor1	10051-101G6	94.96	6.81	2.98	0.43
heart, adult, pool1	10016-101C7	98.66	3.68	10.12	0.92
heart, fetal, pool1	10046-101G1	97.03	3.49	1.64	1.44
hepatic mesenchymal tumor cell line:LI90	10778-110G4	112.30	4.94	10.80	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	74.92	2.38	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	100.00	7.40	13.92	1.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	102.44	9.10	18.45	1.34
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	99.44	6.16	15.46	1.52
hepatoma cell line:Li-7	10484-107A7	55.39	2.78	3.89	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	42.01	2.21	3.12	0.00
hippocampus - adult, donor10196	10169-103B7	162.77	15.14	40.69	0.95
hippocampus, adult, donor10252	10153-102I9	144.71	5.71	13.27	3.47
hippocampus, adult, donor10258	10374-105G5	178.76	9.96	2.49	1.00
hippocampus, newborn, donor10223	10363-105F3	56.75	3.52	8.81	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	122.07	13.43	42.72	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	65.98	4.12	6.68	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	66.01	1.27	23.10	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	84.58	1.69	26.50	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	80.30	3.87	24.27	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	74.02	3.42	27.71	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	87.59	3.50	13.14	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	91.34	3.45	13.36	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	79.66	2.92	17.10	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	82.40	3.08	9.71	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	78.11	3.38	19.13	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	84.16	4.71	8.75	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	59.15	4.38	33.33	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	67.31	1.97	25.06	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	60.22	3.49	34.91	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	113.97	5.92	32.84	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	125.15	4.36	28.78	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	99.45	3.50	46.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	71.59	1.88	11.30	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	92.31	2.27	24.55	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	68.91	2.19	21.93	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	64.34	3.43	17.31	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	66.19	4.06	21.19	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	52.01	2.09	27.50	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	70.20	3.69	8.68	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	66.47	5.71	21.68	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	90.24	6.53	30.62	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	98.93	5.99	10.56	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	85.20	2.85	15.84	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	65.37	4.24	16.34	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	74.98	3.10	9.31	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	73.06	3.32	6.64	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	66.70	2.82	4.36	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	70.81	2.05	8.44	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	90.87	0.00	4.54	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	47.05	2.02	13.11	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	72.93	4.59	17.63	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	65.96	2.23	23.17	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	71.22	4.88	20.98	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	93.52	3.67	10.09	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	458.71	32.53	104.10	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	101.27	2.98	22.17	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	93.04	3.83	7.11	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	70.21	4.70	8.32	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	58.72	1.42	7.12	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	50.12	2.39	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	95.20	3.52	7.85	2.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	59.81	2.16	15.89	0.54
immature langerhans cells, donor1	11904-125F5	317.21	10.65	2.66	1.70
immature langerhans cells, donor2	11905-125F6	75.25	0.79	3.17	0.79
insula, adult, pool1	10039-101F3	151.89	13.15	2.37	3.41
keratoacanthoma cell line:HKA-1	10791-110H8	46.50	0.33	5.85	0.33
kidney, adult, pool1	10017-101C8	76.30	3.70	3.20	1.20
kidney, fetal, pool1	10045-101F9	77.31	6.22	2.05	1.27
large cell lung carcinoma cell line:IA-LM	10509-107D5	170.57	9.09	10.08	2.84
large cell lung carcinoma cell line:NCI-H460	10839-111E2	23.50	2.49	0.97	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	49.73	0.92	2.39	0.18
left atrium, adult, donor1	10079-102A7	62.66	5.45	8.17	0.54
left ventricle, adult, donor1	10078-102A6	63.71	2.53	9.10	0.51
leiomyoblastoma cell line:G-402	10721-110A1	135.44	6.02	6.29	3.28
leiomyoma cell line:10964C	10569-108B2	29.82	1.08	3.95	1.08
leiomyoma cell line:15242A	10570-108B3	44.57	0.54	2.17	0.54
leiomyoma cell line:15425	10571-108B4	50.26	2.19	8.74	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	88.89	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	62.73	7.32	5.23	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	72.96	4.37	2.60	0.47
liposarcoma cell line:KMLS-1	10782-110G8	51.39	3.12	2.34	0.94
liposarcoma cell line:SW 872	10726-110A6	114.77	8.41	9.26	1.22
liver, adult, pool1	10018-101C9	68.23	2.27	4.21	0.32
liver, fetal, pool1	10086-102B5	53.62	4.70	5.64	0.00
locus coeruleus - adult, donor10196	10182-103D2	156.32	11.23	16.48	7.29
locus coeruleus, adult, donor10252	10165-103B3	165.36	11.07	12.73	8.12
locus coeruleus, adult, donor10258	10375-105G6	82.38	5.08	38.94	10.16
locus coeruleus, newborn, donor10223	10362-105F2	63.09	2.94	11.78	2.10
lung adenocarcinoma cell line:A549	10499-107C4	60.06	2.63	12.04	1.38
lung adenocarcinoma cell line:PC-14	10408-106B3	73.77	0.69	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	109.67	5.80	3.69	1.19
lung, adult, pool1	10019-101D1	83.28	2.95	3.31	0.71
lung, fetal, donor1	10068-101I5	134.71	5.14	1.71	1.14
lung, right lower lobe, adult, donor1	10075-102A3	76.52	3.67	8.25	0.92
lymph node, adult, donor1	10077-102A5	58.70	1.89	11.36	0.00
lymphangiectasia cell line:DS-1	10727-110A7	50.19	2.63	10.30	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	104.44	6.79	11.02	1.66
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	109.58	2.55	0.85	0.85
mature adipocyte, donor1	12231-129F8	62.60	1.78	3.55	0.44
mature adipocyte, donor2	12232-129F9	106.88	2.91	1.04	0.21
mature adipocyte, donor3	12233-129G1	75.86	2.84	2.13	0.47
mature adipocyte, donor4	12234-129G2	67.91	1.58	0.53	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	97.45	2.62	3.57	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	206.43	20.30	21.43	4.51
medial frontal gyrus, adult, donor10252	10150-102I6	152.83	11.03	12.32	2.02
medial frontal gyrus, adult, donor10258	10368-105F8	163.29	10.80	8.26	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	91.69	7.68	14.07	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	131.29	9.45	14.18	2.87
medial temporal gyrus, adult, donor10252	10156-103A3	165.32	11.67	11.67	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	169.51	7.71	3.85	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	488.02	57.41	2339.64	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	54.20	1.79	9.33	1.79
medulla oblongata - adult, donor10196	10174-103C3	187.55	6.49	18.82	6.49
medulla oblongata, adult, donor10252	10155-103A2	134.21	7.89	8.82	3.56
medulla oblongata, adult, pool1	10038-101F2	167.58	12.08	2.94	9.39
medulla oblongata, newborn, donor10223	10361-105F1	59.72	2.08	17.36	1.74
medulloblastoma cell line:D283 Med	10838-111E1	76.39	5.98	7.09	0.22
medulloblastoma cell line:ONS-76	10759-110E3	49.15	2.57	1.96	0.98
melanoma cell line:COLO 679	10514-107E1	49.16	3.45	10.49	0.72
melanoma cell line:G-361	10465-106H6	28.23	1.90	1.90	0.27
meningioma cell line:HKBMM	10691-109F7	52.28	0.72	6.51	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	101.33	7.93	7.05	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	109.13	5.18	12.18	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	58.46	4.60	4.91	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	35.63	2.36	3.64	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	49.28	2.90	4.14	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	51.98	2.67	2.81	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	42.75	3.27	5.01	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	40.95	2.08	5.55	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	55.95	3.09	3.95	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	40.72	3.91	2.30	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	53.59	4.91	7.30	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	65.63	4.86	5.54	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	88.06	6.40	1.99	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	45.12	1.98	4.28	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	70.02	5.81	2.63	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	45.38	4.54	12.57	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	45.12	3.27	3.47	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	42.42	2.16	4.31	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	44.79	3.52	2.28	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	48.11	2.05	2.51	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	111.18	5.45	3.36	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	61.42	4.03	4.63	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	69.50	4.90	4.81	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	58.54	3.31	4.42	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	48.07	2.58	6.01	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	55.57	2.11	5.89	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	38.82	2.28	1.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	34.79	2.30	2.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	38.22	2.36	1.05	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	35.74	0.62	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	34.60	1.41	0.94	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	37.57	2.03	1.35	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	36.55	2.75	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	24.10	0.93	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	39.51	2.60	0.87	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	35.25	2.01	0.22	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	30.77	1.20	0.72	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	63.07	3.67	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	26.85	2.01	0.34	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	25.38	2.05	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	34.79	1.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	41.57	0.97	3.57	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	34.92	2.91	7.27	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	36.25	0.00	5.86	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	25.35	1.64	4.09	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	38.87	0.78	3.50	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	37.78	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	22.85	0.99	1.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	34.98	1.78	1.19	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	32.90	1.22	4.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	33.57	1.27	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	41.73	1.38	4.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	0.00	6.89	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	16.30	0.00	3.67	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.04	0.79	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.99	1.77	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	24.00	3.43	0.62	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	28.07	1.34	2.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	23.65	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	0.00	2.57	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	31.67	2.75	4.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	33.65	1.48	2.97	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	29.16	1.12	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	33.08	0.64	2.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	33.45	1.61	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	37.07	0.00	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	24.07	1.27	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	28.52	0.00	1.82	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	0.00	22.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	22.24	0.82	3.29	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	25.20	1.19	4.17	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	29.53	2.60	2.27	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	25.47	2.04	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	91.30	3.09	0.77	3.09
mesothelioma cell line:ACC-MESO-1	10493-107B7	84.81	2.60	5.43	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	115.84	5.10	10.89	2.78
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	51.28	0.00	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	26.20	1.75	0.72	0.82
mesothelioma cell line:Mero-25	10850-111F4	78.98	2.95	9.31	1.13
mesothelioma cell line:Mero-41	10851-111F5	63.81	4.16	3.42	0.73
mesothelioma cell line:Mero-48a	10852-111F6	63.77	4.65	6.86	1.11
mesothelioma cell line:Mero-82	10853-111F7	37.06	1.84	4.47	0.00
mesothelioma cell line:Mero-83	10854-111F8	68.94	4.77	6.64	1.70
mesothelioma cell line:Mero-84	10855-111F9	63.95	2.02	4.30	0.76
mesothelioma cell line:Mero-95	10856-111G1	66.05	2.69	3.73	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	91.27	2.98	5.47	1.82
mesothelioma cell line:NCI-H226	10846-111E9	58.64	3.26	6.70	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	82.34	3.25	11.27	0.85
mesothelioma cell line:NCI-H28	10845-111E8	49.62	1.02	3.82	0.00
mesothelioma cell line:No36	10857-111G2	52.84	3.91	5.22	1.30
mesothelioma cell line:ONE58	10858-111G3	44.71	1.35	0.81	0.54
migratory langerhans cells, donor1	11901-125F2	108.63	4.61	1.34	1.15
migratory langerhans cells, donor2	11902-125F3	81.57	2.93	0.49	0.61
migratory langerhans cells, donor3	11903-125F4	88.12	6.28	2.15	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	49.95	1.96	2.29	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	30.31	2.76	7.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	147.66	6.22	2.76	1.15
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	31.21	1.52	1.90	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	72.81	3.14	8.87	0.92
myeloma cell line:PCM6	10474-106I6	28.07	0.20	1.19	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	66.96	4.06	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	29.81	2.16	1.77	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	71.98	1.67	7.47	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	63.32	1.84	2.13	0.29
nasal epithelial cells, donor2	12227-129F4	71.76	2.21	3.31	0.00
neuroblastoma cell line:CHP-134	10508-107D4	190.26	9.89	23.93	1.15
neuroblastoma cell line:NB-1	10539-107G8	148.17	16.09	16.46	1.68
neuroblastoma cell line:NBsusSR	10607-108F4	120.63	4.85	5.48	0.42
neuroblastoma cell line:NH-12	10555-107I6	216.54	16.59	16.77	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	57.17	1.66	6.88	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	103.42	4.75	20.91	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	86.74	4.83	13.48	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	106.81	5.72	4.45	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	86.50	3.19	7.98	1.86
neutrophil PMN, donor1	12133-128D9	119.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	104.18	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	105.36	5.07	3.21	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	60.04	4.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	41.04	3.85	5.77	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	40.47	1.05	1.58	0.53
nucleus accumbens, adult, pool1	10037-101F1	143.05	13.40	2.91	3.66
occipital cortex - adult, donor10196	10172-103C1	271.97	16.48	16.48	2.06
occipital cortex, adult, donor10252	10163-103B1	185.71	13.15	19.05	2.42
occipital cortex, newborn, donor10223	10355-105E4	67.69	1.46	6.55	0.00
occipital lobe, adult, donor1	10076-102A4	164.00	14.96	39.88	1.84
occipital lobe, fetal, donor1	10073-102A1	220.99	14.16	24.03	0.86
occipital pole, adult, pool1	10036-101E9	133.56	13.95	1.81	4.02
olfactory region, adult	10195-103E6	133.16	12.04	11.46	1.72
optic nerve, donor1	10277-104E7	310.16	10.01	20.01	20.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	93.52	3.99	2.62	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	65.81	2.75	3.02	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	49.44	2.88	2.71	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	54.40	4.16	2.89	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	77.31	2.94	3.53	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	584.89	32.70	1.87	4.67
osteosarcoma cell line:HS-Os-1	10558-107I9	54.08	4.67	7.21	0.42
ovary, adult, pool1	10020-101D2	74.95	3.06	1.83	1.48
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	58.85	4.03	11.92	0.73
pancreas, adult, donor1	10049-101G4	89.36	1.88	24.46	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	65.97	2.80	8.67	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	85.35	3.41	12.95	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	117.73	3.97	7.62	0.66
paracentral gyrus, adult, pool1	10035-101E8	145.61	14.00	2.56	3.39
parietal cortex, adult, donor10258	10373-105G4	131.39	8.07	0.73	4.40
parietal lobe - adult, donor10196	10171-103B9	193.74	6.58	31.04	5.64
parietal lobe, adult, donor10252	10157-103A4	139.95	12.54	6.84	2.85
parietal lobe, adult, pool1	10034-101E7	160.47	15.24	8.81	5.55
parietal lobe, fetal, donor1	10072-101I9	215.30	13.58	14.55	0.00
parietal lobe, newborn, donor10223	10356-105E5	68.79	3.36	12.34	0.75
parotid gland, adult	10199-103F1	45.63	2.47	5.55	0.00
penis, adult	10200-103F2	54.25	2.15	4.30	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	41.65	0.19	0.74	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	69.79	2.33	12.53	0.00
pineal gland - adult, donor10196	10179-103C8	163.84	8.39	7.10	1.29
pineal gland, adult, donor10252	10160-103A7	165.82	9.48	14.81	1.78
pineal gland, adult, donor10258	10377-105G8	92.18	7.52	1.88	2.51
pituitary gland - adult, donor10196	10180-103C9	200.34	8.09	17.20	4.05
pituitary gland, adult, donor10252	10162-103A9	190.75	9.90	12.51	4.17
pituitary gland, adult, donor10258	10378-105G9	99.60	2.55	4.26	7.66
placenta, adult, pool1	10021-101D3	104.17	7.20	3.44	1.18
plasma cell leukemia cell line:ARH-77	10840-111E3	32.05	2.25	0.93	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	54.32	3.27	5.29	0.78
pons, adult, pool1	10033-101E6	171.88	15.75	3.36	7.23
postcentral gyrus, adult, pool1	10032-101E5	147.50	12.73	8.46	5.32
promyelocytes/myelocytes PMC, donor1	12132-128D8	127.58	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	97.59	6.41	27.82	1.75
prostate cancer cell line:PC-3	10439-106E7	133.59	5.63	9.80	1.27
prostate, adult, pool1	10022-101D4	67.47	2.27	3.17	1.54
putamen, adult, donor10196	10176-103C5	147.54	4.72	16.29	1.65
putamen, adult, donor10252	10152-102I8	92.15	5.88	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	130.04	3.28	3.28	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	113.80	5.32	12.08	2.66
putamen, newborn, donor10223	10365-105F5	53.98	2.25	23.24	1.50
rectal cancer cell line:TT1TKB	10469-106I1	79.43	4.07	3.49	0.29
rectum, fetal, donor1	10067-101I4	133.54	6.95	18.08	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	49.61	3.60	1.06	1.70
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	57.99	2.90	4.56	0.83
retina, adult, pool1	10030-101E3	94.93	5.27	7.95	1.69
retinoblastoma cell line:Y79	10475-106I7	88.33	6.50	5.46	2.34
rhabdomyosarcoma cell line:KYM-1	10787-110H4	110.90	6.89	13.16	2.58
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	137.23	10.69	18.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	84.12	3.79	0.76	0.76
salivary acinar cells, donor1	11771-123I7	48.23	3.08	2.10	1.13
salivary acinar cells, donor2	11772-123I8	34.56	3.17	1.38	2.20
salivary acinar cells, donor3	11773-123I9	56.94	3.97	1.99	0.66
salivary gland, adult, pool1	10093-102C3	104.10	6.86	5.72	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	93.67	3.63	3.63	1.43
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	103.45	4.47	6.47	1.65
seminal vesicle, adult	10201-103F3	80.95	3.70	1.59	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	58.79	1.94	3.40	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	72.72	3.77	2.77	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	67.24	3.01	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	65.95	2.55	5.51	1.21
signet ring carcinoma cell line:Kato III	10436-106E4	138.71	4.20	3.98	0.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	94.45	3.61	4.13	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	57.46	0.00	1.42	1.42
skeletal muscle, adult, pool1	10023-101D5	52.29	2.16	3.12	0.72
skeletal muscle, fetal, donor1	10066-101I3	35.18	3.02	6.03	0.00
skin, adult, donor1	10074-102A2	74.64	0.00	13.57	0.00
skin, fetal, donor1	10065-101I2	110.46	7.57	21.46	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	94.72	7.34	8.00	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	129.55	6.93	15.45	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	42.60	1.73	4.43	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	95.43	7.91	5.77	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	46.32	2.90	2.25	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	152.76	6.76	3.27	1.31
small intestine, adult, pool1	10024-101D6	77.52	2.15	10.03	0.60
small intestine, fetal, donor1	10064-101I1	64.13	2.46	7.62	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	37.95	0.00	4.62	0.51
smooth muscle, adult, pool1	10048-101G3	64.61	4.91	8.01	2.07
somatostatinoma cell line:QGP-1	10781-110G7	105.06	5.90	4.02	0.54
spinal cord - adult, donor10196	10181-103D1	163.11	8.95	21.11	10.78
spinal cord, adult, donor10252	10159-103A6	149.82	4.34	9.07	15.77
spinal cord, adult, donor10258	10369-105F9	161.19	11.07	3.46	9.69
spinal cord, fetal, donor1	10056-101H2	146.36	9.15	19.51	3.66
spinal cord, newborn, donor10223	10359-105E8	118.02	3.21	17.91	4.59
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	99.77	5.38	6.42	1.34
spleen, adult, pool1	10025-101D7	75.11	2.75	1.87	0.77
spleen, fetal, pool1	10044-101F8	64.91	2.62	1.35	1.11
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	44.82	2.79	2.48	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	51.46	1.52	2.09	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	99.59	3.15	11.53	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	80.14	3.13	3.13	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	67.31	2.81	4.95	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	64.81	2.12	1.27	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	92.23	3.38	0.42	0.42
stomach, fetal, donor1	10062-101H8	175.15	3.20	10.68	1.07
submaxillary gland, adult	10202-103F4	55.83	2.28	2.85	2.85
substantia nigra - adult, donor10196	10178-103C7	379.92	0.00	1682.50	0.00
substantia nigra, adult, donor10252	10158-103A5	169.07	5.40	13.50	7.89
substantia nigra, adult, donor10258	10371-105G2	180.00	7.76	1.55	4.14
substantia nigra, newborn, donor10223	10358-105E7	47.34	1.41	5.65	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	72.91	4.59	6.65	0.92
temporal lobe, adult, pool1	10031-101E4	118.09	12.72	3.81	3.31
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	207.27	9.26	22.79	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	136.70	3.52	3.96	0.44
tenocyte, donor1	11763-123H8	73.66	2.79	2.09	1.05
tenocyte, donor2	11765-123I1	53.03	1.14	8.39	0.76
tenocyte, donor3	11768-123I4	60.42	2.97	4.45	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	131.89	7.65	9.18	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	69.52	4.16	9.25	0.77
teratocarcinoma cell line:PA-1	10807-111A6	116.85	9.45	22.16	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	83.15	5.33	17.01	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	79.04	7.19	1.51	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	81.47	5.23	2.29	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	51.46	1.95	4.56	0.33
testis, adult, pool1	10026-101D8	114.57	5.80	6.98	6.66
testis, adult, pool2	10096-102C6	198.93	7.22	4.06	14.89
thalamus - adult, donor10196	10168-103B6	200.93	7.73	37.54	9.94
thalamus, adult, donor10252	10154-103A1	146.91	5.78	11.10	5.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	306.38	7.70	3.08	7.70
thalamus, adult, donor10258, tech_rep2	10370-105G1	62.09	3.79	25.86	5.11
thalamus, newborn, donor10223	10366-105F6	65.01	3.45	19.56	2.88
throat, adult	10209-103G2	62.42	1.25	5.24	1.50
throat, fetal, donor1	10061-101H7	90.19	4.88	7.92	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	93.80	6.76	7.35	3.38
thymus, adult, pool1	10027-101D9	72.47	2.19	0.99	0.70
thymus, fetal, pool1	10043-101F7	94.55	2.18	2.29	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	50.13	2.79	11.04	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	132.85	5.87	10.90	0.28
thyroid, adult, pool1	10028-101E1	109.92	6.53	4.01	0.75
thyroid, fetal, donor1	10060-101H6	104.67	7.12	12.13	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	132.42	6.16	3.08	6.16
tongue, adult	10203-103F5	42.56	1.63	2.56	0.70
tongue, fetal, donor1	10059-101H5	73.30	4.34	10.64	0.79
tonsil, adult, pool1	10047-101G2	79.54	3.71	2.70	0.90
trachea, adult, pool1	10029-101E2	65.52	3.44	2.04	0.74
trachea, fetal, donor1	10058-101H4	82.32	5.00	11.16	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	61.64	4.61	17.01	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	59.47	3.75	1.32	0.91
transitional-cell carcinoma cell line:JMSU1	10492-107B6	87.74	4.23	9.71	1.10
tridermal teratoma cell line:HGRT	10694-109G1	119.86	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	151.69	6.18	11.09	0.59
umbilical cord, fetal, donor1	10057-101H3	54.25	6.26	14.61	0.00
uterus, adult, pool1	10100-102D1	127.80	4.44	6.31	2.05
uterus, fetal, donor1	10055-101H1	83.44	3.07	18.94	1.02
vagina, adult	10204-103F6	76.90	4.52	1.29	0.00
vein, adult	10191-103E2	58.75	3.07	2.85	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	36.05	2.40	5.61	0.00